Study led by Manitoba doctor shows promising treatment for COVID-19 patients
A global trial led by Winnipeg and Canadian researchers is showing promising results in treating some COVID-19 cases.
Dr. Ryan Zarychanski’s study on blood thinners in COVID positive patients was published Wednesday in the New England Journal of Medicine.
The study found that treating some hospitalized patients with blood thinners increases their chance of survival and reduces their need for intensive care.
"A blood thinner drug that has anti-inflammatory and antiviral properties has been shown in our large global trial to increase survival without the need for ICU-level care," said Zarychanski.
That drug is heparin, an inexpensive and widely available medication used to treat blood clots. Blood clots and inflammation were noted early on in the pandemic as serious complications of COVID-19.
“For us to demonstrate that a drug that is incredibly inexpensive, widely available around the world and familiar to doctors all over the globe, for us to demonstrate that this drug could be used too, and can save lives and reduce the burden of critical illness on health-care systems is a huge win,” said Zarychanski.
The findings could impact patient care immediately, with Zarychanski saying physicians within organized health-care systems could start using heparin molecules to treat patients admitted to hospital with the virus, but who are not yet critically ill.
"We think it will reduce the burden of critical illness due to COVID-19 by approximately 25 per cent when used in health systems that adopt that therapy," said Zarychanski.
While results in December of 2020 showed no benefits to those already critically ill, the researchers say it could be a key tool in saving the lives of non-critically ill patients by knowing who to target.
The study was also the first of its kind, a clinical trial on a global scale during a pandemic. Zarychanski said the methods developed during the study will change how researchers approach large-scale clinical trials in the future.
“We developed methods that allowed independent platforms, so independent research entities can still maintain their independence but work collaboratively,” said Zarychanski.
The trial spanned five continents and involved patients from 300 hospitals.
CTVNews.ca Top Stories
Ottawa public school board, 3 Toronto-area school boards launch lawsuit against social media giants
The Ottawa-Carleton District School Board and three school boards in the Toronto-area have launched legal action against social media giants, accusing them of "disrupting students' fundamental right to education."
Several flight attendants from Pakistan have gone missing after landing in Canada
Multiple flight attendants from Pakistan International Airlines have abandoned their jobs and are believed to have sought asylum in Canada in the past year and a half, a spokesperson for the government-owned airline says.
Tipping is off the table at this Toronto restaurant
A Toronto restaurant introduced a surprising new rule that reduced the cost of a meal and raised the salaries of staff.
Rainfall warnings of up to 90 mm among weather alerts in effect for 7 provinces
Rainfall warnings of up to 90 millimetres, air quality advisories and other alerts have been issued for seven Canadian provinces, according to the latest forecasts.
King Charles calls for acts of friendship in first public remarks since Kate's cancer diagnosis
King Charles III gave public remarks for Maundy Thursday, addressing the importance of acts of friendship, following his and Catherine, Princess of Wales’ cancer diagnoses.
A Nigerian woman reviewed some tomato puree online. Now she faces jail
A Nigerian woman who wrote an online review of a can of tomato puree is facing imprisonment after its manufacturer accused her of making a “malicious allegation” that damaged its business.
Donald Trump assails judge and his daughter after gag order in N.Y. hush-money criminal case
Donald Trump lashed out Wednesday at the New York judge who put him under a gag order that bars him from commenting publicly about witnesses, prosecutors, court staff and jurors in his upcoming hush-money criminal trial.
A fight to protect the dignity of Michelangelo's David raises questions about freedom of expression
Michelangelo's David has been a towering figure in Italian culture since its completion in 1504. But in the current era of the quick buck, curators worry the marble statue's religious and political significance is being diminished.
Doctors visiting a Gaza hospital are stunned by the war's toll on Palestinian children
An international team of doctors visiting a hospital in central Gaza was prepared for the worst. But the gruesome impact Israel’s war against Hamas is having on Palestinian children still left them stunned.